Armistice Capital »

Kalvista Pharmaceuticals shares owned by Armistice Capital

Quarter-by-quarter ownership of Kalvista Pharmaceuticals (KALV) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Kalvista Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Kalvista Pharmaceuticals held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kalvista Pharmaceuticals by Armistice Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $25M 1.2M 20.13

More positions owned by Armistice Capital

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Agios Pharmaceuticals (AGIO)
Cytokinetics Com New (CYTK)
Ptc Therapeutics I (PTCT)
Travere Therapeutics (TVTX)
Madrigal Pharmaceuticals (MDGL)
Immunovant (IMVT)
Supernus Pharmaceuticals (SUPN)
Neurocrine Biosciences (NBIX)
Freshpet (FRPT)
Incyte Corporation (INCY)
Dyne Therapeutics (DYN)
Amazon (AMZN)
Ironwood Pharmaceuticals Com Cl A (IRWD)

View all positions for Armistice Capital

Top funds holding Kalvista Pharmaceuticals

VR Adviser
Frazier Life Sciences Management
Suvretta Capital Management
Tang Capital Management
BlackRock
Capital World Investors
Vanguard Group
Silverarc Capital Management
Point72 Asset Management
Millennium Management
State Street Corporation
Vestal Point Capital
Vanguard Capital Management
Kynam Capital Management
Parkman Healthcare Partners

View all funds holding Kalvista Pharmaceuticals